Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

M. W. Schuster, E. Anaissie, D. Hurd, W. Bensinger, J. Mason, J. McCarty, R. Rifkin, R. Maziarz, Y. Halvorsen, V. Annino, W. Hahne

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)58-59
Number of pages2
JournalJournal of Supportive Oncology
Issue number4 SUPPL. 2
StatePublished - Apr 2007

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this